A Letter From Our CEO
CEO Bruno Lempernese talks about Carevive's significant milestones achieved in the first half of 2023.
CareviveSeptember 6, 2023
Describing the patient experience of acute myeloid leukemia treatment in the era of novel therapies: interim results of a longitudinal patient-reported outcomes study
Patients with AML on low-intensity treatment regimens have unmet supportive care needs.
CareviveJune 5, 2023
Symptom Burden in Late-Stage Breast Cancer Patients Treated with CDK Inhibitors Using the PRO-CTCAE
The objective of this study is to use electronic patient-reported outcome (ePRO) and a remote symptom monitoring platform to evaluate symptom differences among late-stage breast cancer patients with and without CDKI treatmen
CareviveMay 18, 2023
Real-world Severe Symptom Trajectory in Multiple Myeloma Reported in Remote Symptom Monitoring with Electronic Patient-Reported Outcomes (ePRO)
This study aims to describe the severe symptom trajectory in MM population who utilized remote symptom monitoring with ePRO.
CareviveMay 18, 2023
Real-World Pain Symptom Trajectory Among Multiple Myeloma Patients Under Remote Symptom Monitoring With Electronic Patient-Reported Outcomes (ePRO)
This study highlights the importance of monitoring and addressing pain in MM patients, as pain at baseline may be associated with a higher symptom burden during treatment.
CareviveMay 18, 2023
Feasibility of Real-World Assessment of Patient-Reported Outcomes in Acute Myeloid Leukemia by Cytogenetic Risk and Treatment Status
In this study, we used electronic patient-reported outcomes (ePRO) through a remote symptom monitoring program in MM patients experiencing variable levels of pain.
CareviveMay 18, 2023
Carevive releases a Spanish version of their remote patient monitoring workflow to reach more patients and reduce barriers to care
March 29, 2023 – Boston, MA – Carevive Systems (“Carevive”) the leading oncology-focused health technology company is centered on understanding and improving the experience of patients with cancer using their unique Patient-Reported Outcomes Mobile Platform (PROmpt). Carevive PROmpt® enables cancer patients to report new symptoms and receive valuable information about their treatment while at the same time providing clinicians a way to monitor their patients’ health and…
CareviveMarch 29, 2023
Podcast #20: Revenue Enhancing Opportunities – The Switch from OCM to EOM
In the latest episode of “Oncology and Technology,” host Tyler Kern sat down to interview with several members of the Carevive team, John Elliot, VP of Sales; Reesa Sherin, Clinical Strategist; and April Boyd, Clinical Product Manager, mostly about the state of the oncology, and what current trends will remain or seeing advancements next year.
CareviveMarch 9, 2023
Carevive Launches Native App Technology for the Carevive PROmpt® Patient Engagement Platform
Carevive announced that it will be launching a new native app option for PROmpt to better facilitate the collection of critical patient data and the communication between cancer patients and their care teams
CareviveMarch 1, 2023
Leading Oncology Patient-Reported Outcomes Technology Company Launches Commercialization of Computerized Cancer Symptom Management Pathways
Carevive Systems, Inc., a leading innovator in cancer care management software with a deep real-world evidence patient dataset, announced today that it will launch the commercialization of its computerized cancer symptom management pathways.
CareviveFebruary 16, 2023